Literature DB >> 23152731

Irritable bowel syndrome: how useful is the term and the 'diagnosis'?

Michael Camilleri1.   

Abstract

Entities:  

Year:  2012        PMID： 23152731      PMCID： PMC3491678          DOI： 10.1177/1756283X12442223

Source DB:  PubMed          Journal:  Therap Adv Gastroenterol        ISSN： 1756-283X            Impact factor:   4.409


× No keyword cloud information.
  31 in total

1.  Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome.

Authors:  G C Parkes; N B Rayment; B N Hudspith; L Petrovska; M C Lomer; J Brostoff; K Whelan; J D Sanderson
Journal:  Neurogastroenterol Motil       Date:  2011-11-09       Impact factor: 3.598

2.  Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study.

Authors:  Smita L S Halder; G Richard Locke; Cathy D Schleck; Alan R Zinsmeister; L Joseph Melton; Nicholas J Talley
Journal:  Gastroenterology       Date:  2007-06-20       Impact factor: 22.682

Review 3.  Opioid-induced constipation: challenges and therapeutic opportunities.

Authors:  Michael Camilleri
Journal:  Am J Gastroenterol       Date:  2011-02-22       Impact factor: 10.864

4.  Regional colon transit in patients with dys-synergic defaecation or slow transit in patients with constipation.

Authors:  Sara Nullens; Tyler Nelsen; Michael Camilleri; Duane Burton; Deborah Eckert; Johanna Iturrino; Maria Vazquez-Roque; Alan R Zinsmeister
Journal:  Gut       Date:  2011-12-16       Impact factor: 23.059

Review 5.  Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies.

Authors:  S S C Rao; M Camilleri; W L Hasler; A H Maurer; H P Parkman; R Saad; M S Scott; M Simren; E Soffer; L Szarka
Journal:  Neurogastroenterol Motil       Date:  2011-01       Impact factor: 3.598

6.  Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease.

Authors:  Michael Camilleri
Journal:  Gut       Date:  2011-02-02       Impact factor: 23.059

Review 7.  Advances in diagnostic assessment of fecal incontinence and dyssynergic defecation.

Authors:  Satish S C Rao
Journal:  Clin Gastroenterol Hepatol       Date:  2010-06-25       Impact factor: 11.382

8.  Gastrointestinal transit abnormalities are frequently detected in patients with unexplained GI symptoms at a tertiary centre.

Authors:  R Sadik; P-O Stotzer; M Simrén; H Abrahamsson
Journal:  Neurogastroenterol Motil       Date:  2007-11-05       Impact factor: 3.598

9.  Prospective study of motor, sensory, psychologic, and autonomic functions in patients with irritable bowel syndrome.

Authors:  Michael Camilleri; Sanna McKinzie; Irene Busciglio; Phillip A Low; Seth Sweetser; Duane Burton; Kari Baxter; Michael Ryks; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05-05       Impact factor: 11.382

10.  A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease.

Authors:  W Kruis; C Thieme; M Weinzierl; P Schüssler; J Holl; W Paulus
Journal:  Gastroenterology       Date:  1984-07       Impact factor: 22.682
View more
  5 in total

1.  What is irritable bowel syndrome?

Authors:  Peter J Whorwell
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

2.  Irritable bowel syndrome: a multidimensional disorder cannot be understood or treated from a unidimensional perspective.

Authors:  Ami D Sperber; Douglas A Drossman
Journal:  Therap Adv Gastroenterol       Date:  2012-11       Impact factor: 4.409

Review 3.  Managing irritable bowel syndrome.

Authors:  Joyce K Anastasi; Bernadette Capili; Michelle Chang
Journal:  Am J Nurs       Date:  2013-07       Impact factor: 2.220

Review 4.  Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview.

Authors:  Theodor Bokic; Martin Storr; Rudolf Schicho
Journal:  Pharmacology       Date:  2015-07-01       Impact factor: 2.547

5.  Associations among neurophysiology measures in irritable bowel syndrome (IBS) and their relevance for IBS symptoms.

Authors:  Irina Midenfjord; Annikka Polster; Henrik Sjövall; Peter Friberg; Hans Törnblom; Magnus Simrén
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.